{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:46:06Z","timestamp":1789577166365,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.arcped.2022.08.015","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T09:53:44Z","timestamp":1663062824000},"page":"480-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum leptin levels in children and adolescents with spinal muscular atrophy types 2 and 3\u2730"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-0068","authenticated-orcid":false,"given":"S.","family":"Djordjevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Milic-Rasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Brankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kosac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Dejanovic-Djordjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bijelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dimkic-Tomic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lj.","family":"Markovic-Denic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vitorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Dobric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Zdravkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2022.08.015_bib0001","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: a timely review","volume":"68","author":"Kolb","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.arcped.2022.08.015_bib0002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"issue":"Suppl 7","key":"10.1016\/j.arcped.2022.08.015_bib0003","first-page":"9","article-title":"Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA)","volume":"27","author":"Rouzier","year":"2020","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2022.08.015_bib0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcped.2022.08.015_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","article-title":"Childhood spinal muscular atrophy: controversies and challenges","volume":"11","author":"Mercuri","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcped.2022.08.015_bib0006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2022.08.015_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2020.01.003","article-title":"Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease","volume":"109","author":"Yeo","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.arcped.2022.08.015_bib0008","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.3390\/ijms22115913","article-title":"Metabolic dysfunction in spinal muscular atrophy","volume":"22","author":"Deguise","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcped.2022.08.015_bib0009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.metabol.2014.08.004","article-title":"Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism","volume":"64","author":"Park","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.arcped.2022.08.015_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1101\/gr.5.1.5","article-title":"The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7","volume":"5","author":"Green","year":"1995","journal-title":"Genome Res"},{"key":"10.1016\/j.arcped.2022.08.015_bib0011","first-page":"2904","article-title":"Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone*","volume":"82","author":"Blum","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2022.08.015_bib0012","first-page":"899","article-title":"Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition1","volume":"84","author":"Ahmed","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2022.08.015_bib0013","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00365513.2016.1210226","article-title":"Reference values for serum leptin in healthy non-obese children and adolescents","volume":"76","author":"Lausten-Thomsen","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.arcped.2022.08.015_bib0014","article-title":"Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III","volume":"12","author":"K\u00f6lbel","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arcped.2022.08.015_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mus.27088","article-title":"Cardiac findings in pediatric patients with spinal muscular atrophy types 2 and 3","volume":"63","author":"Djordjevic","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arcped.2022.08.015_bib0016","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nmd.2021.02.002","article-title":"Glucose and lipid metabolism disorders in children and adolescents with spinal muscular atrophy types 2 and 3","volume":"31","author":"Djordjevic","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2022.08.015_bib0017","unstructured":"Growth charts. Centers for disease control and prevention [Internet]. https:\/\/www.cdc.gov\/growthcharts\/index.htm. Updated September 9, 2010. Accessed September 15, 2021."},{"key":"10.1016\/j.arcped.2022.08.015_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2022.08.015_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2022.08.015_bib0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An expanded version of the hammersmith functional motor scale for SMA II and III patients","volume":"17","author":"O'Hagen","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2022.08.015_bib0021","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/0883073811420294","article-title":"Validation of the expanded hammersmith functional motor scale in spinal muscular atrophy type II and III","volume":"26","author":"Glanzman","year":"2011","journal-title":"J. Child Neurol"},{"issue":"Suppl 7","key":"10.1016\/j.arcped.2022.08.015_bib0022","first-page":"40","article-title":"State of the art for motor function assessment tools in spinal muscular atrophy (SMA)","volume":"27","author":"Vuillerot","year":"2020","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2022.08.015_bib0023","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mus.26823","article-title":"Evaluation of body composition as a potential biomarker in spinal muscular atrophy","volume":"61","author":"Baranello","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arcped.2022.08.015_bib0024","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.nmd.2010.05.013","article-title":"Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy","volume":"20","author":"Sproule","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"Suppl 7","key":"10.1016\/j.arcped.2022.08.015_bib0025","first-page":"18","article-title":"Clinical features of spinal muscular atrophy (SMA) type 2","volume":"27","author":"Canc\u00e8s","year":"2020","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2022.08.015_bib0026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nmd.2009.03.009","article-title":"Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy","volume":"19","author":"Sproule","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2022.08.015_bib0027","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.clnu.2016.10.020","article-title":"Spinal Muscular Atrophy, types I and II: what are the differences in body composition and resting energy expenditure?","volume":"36","author":"Bertoli","year":"2017","journal-title":"Clin Nutr"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X22001853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X22001853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T09:53:43Z","timestamp":1714211623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X22001853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0929693X22001853"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2022.08.015","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum leptin levels in children and adolescents with spinal muscular atrophy types 2 and 3\u2730","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2022.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}